We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Urology

Journal Scan / Research · December 14, 2018

Low-Dose Desmopressin Orally Disintegrating Tablet for Nocturia

European Urology Focus

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Urology Focus
Low-Dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients With Nocturia Due to Nocturnal Polyuria
Eur Urol Focus 2018 Nov 20;[EPub Ahead of Print], JP Weiss, EA van der Meulen, KV Juul

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading